Effects of Ca2+ channel activity on renal hemodynamics during acute attenuation of NO synthesis in the rat

American Journal of Physiology - Renal Physiology

Volumn 278, Issue 4 47-4, 2000, Pages

  Kramp, R A ^a   Fourmanoir, P ^a,c   Ladriere L ^a,b   Joly, E ^a   Gerbaux, C ^a   El Hajjam, A ^a   Caron, N ^a  

^a UNIVERSITY OF MONS   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c Baxter R and D Europe   (Belgium)

Author keywords

Autoregulation; Iberiotoxin; Nifedipine; Renal vascular resistance

Indexed keywords

CALCIUM CHANNEL; N(G) NITROARGININE METHYL ESTER; NIFEDIPINE; NITRIC OXIDE; POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ARTICLE; AUTOREGULATION; CONTROLLED STUDY; KIDNEY BLOOD FLOW; KIDNEY VASCULAR RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0034003848     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.2000.278.4.f561     Document Type: Article

References (37)

1. Archer S, Huang JMC, Hampl V, Nelson DP, Schultz PJ, and Weir EK. Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc Natl Acad Sci USA 91: 7583-7587, 1994.
2. Aukland K. Myogenic mechanisms in the kidney. J Hypertens 4: S71-S76, 1989.
3. Baumann JE, Persson PB, Ehmke H, Nafz B, and Kirchheim HR. Role of endothelium-derived relaxing factor in renal autoregulation in conscious dogs. Am J Physiol Renal Fluid Electrolyte Physiol 263: F208-F213, 1992.
4. Baylis C, Harton P, and Engels K. Endothelial derived relaxing factor controls renal hemodynamics in the normal rat kidney. J Am Soc Nephrol 1: 875-881, 1990.
5. Baylis C, Masilamani S, Losonczy G, Samsell L, Harton P, and Engels K. Blood pressure (BP) and renal vasoconstrictor responses to acute blockade of nitric oxide: persistence of renal vasoconstriction despite normalization of BP with either verapamil or sodium nitroprusside. J Pharmacol Exp Ther 274: 1135-1141, 1995.
6. Beierwaltes WH, Sigmon DH, and Carretero OA. Endothelium modulates renal blood flow but not autoregulation. Am J Physiol Renal Fluid Electrolyte Physiol 262: F943-F949, 1992.
7. i in vascular smooth muscle by inhibition of the calcium current. Cell Calcium 15: 122-131, 1994.
8. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, and Cohen RA. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368: 850-853, 1994.
9. Bouriquet N and Casellas D. Interaction between cGMP-dependent dilators and autoregulation in rat preglomerular vasculature. Am J Physiol Renal Fluid Electrolyte Physiol 268: F338-F346, 1995.
10. Carmines PK and Navar LG. Disparate effects of Ca channel blockade on afferent and efferent arteriolar responses to ANG II. Am J Physiol Renal Fluid Electrolyte Physiol 256: F1015-F1020, 1989.
11. Casellas D and Moore LC. Autoregulation and tubuloglomerular feedback in juxtamedullary glomerular arterioles. Am J Physiol Renal Fluid Electrolyte Physiol 258: F660-F669, 1990.
12. Cohen A. The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease. Prog Cardiovasc Dis 38: 105-128, 1995.
13. Dijkhorst-Oei LT, Rabelink TJ, Boer P, and Koomans HA. Nifedipine attenuates systemic and renal vasoconstriction during nitric oxide inhibition in humans. Hypertension 29: 1192-1198, 1997.
14. + channels in rat renal arterioles. Am J Physiol Renal Fluid Electrolyte Physiol 270: F69-F81, 1996.
15. Godfraind T, Miller R, and Wibo M. Calcium antagonism and calcium entry blockade. Pharmacol Rev 38: 324-392, 1986.
16. Hoffend J, Cavarape A, Endlich K, and Steinhausen M. Influence of endothelium-derived relaxing factor on renal microvessels and pressure-dependent vasodilation. Am J Physiol Renal Fluid Electrolyte Physiol 265: F285-F292, 1993.
17. Huang C and Johns EJ. Effect of nitrendipine on renal cortical and papillary autoregulation in hypertensive rats. Eur J Pharmacol 282: 1-10, 1995.
18. Ignarro J. Endothelium-derived nitric oxide: actions and properties. FASEB J 3: 31-36, 1989.
19. Ignarro LJ, Harbison RG, Woord KS, and Kadowitz PJ. Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid. J Pharmacol Exp Ther 237: 893-900, 1986.
20. Imig JD and Roman RJ. Nitric oxide modulates vascular tone in preglomerular arteries. Hypertension 19: 770-774, 1992.
21. Kramp RA, Genard J, Fourmanoir P, Caron N, Lackeman G, and Herman A. Renal hemodynamics and blood flow autoregulation during acute cyclooxygenase inhibition in male rats. Am J Physiol Renal Fluid Electrolyte Physiol 268: F468-F479, 1995.
22. Kvam FI, Ofstad J, and Iversen BM. Effects of antihypertensive drugs on autoregulation of RBF and glomerular capillary pressure in SHR. Am J Physiol Renal Physiol 275: F576-F584, 1998.
23. Majid DSA and Navar LG. Suppression of blood flow autoregulation plateau during nitric oxide blockade in canine kidney. Am J Physiol Renal Fluid Electrolyte Physiol 262: F40-F46, 1992.
24. Milbourne EA and Bygrave FL. Do nitric oxide and cGMP play a role in calcium cycling? Cell Calcium 18: 207-213, 1995.
25. Mitchell KD and Navar LG. Tubuloglomerular feedback responses during peritubular infusions of calcium channel blockers. Am J Physiol Renal Fluid Electrolyte Physiol 258: F537-F544, 1990.
26. Navar G. Renal autoregulation: perspectives from whole kidney and single nephron studies. Am J Physiol Renal Fluid Electrolyte Physiol 234: F357-F370, 1978.
27. Navar G. Integrating multiple paracrine regulators of renal microvascular dynamics. Am J Physiol Renal Physiol 274: F433-F444, 1998.
28. Navar LG, Champion WJ, and Thomas CE. Effects of calcium channel blockade on renal vascular resistance responses to changes in perfusion pressure and angiotensin-converting enzyme inhibition in dogs. Circ Res 58: 874-881, 1986.
29. Persson P, Ehmke H, and Kirchheim H. Influence of the renin-angiotensin system on the autoregulation of renal blood flow and glomerular filtration rate in conscious dogs. Acta Physiol Scand 134: 1-7, 1988.
30. Rabelink TJ and Koomans HA. Endothelial function and the kidney. An emerging target for cardiovascular therapy. Drugs 53, Suppl 1: 11-19, 1997.
31. Ruan X and Arendshorst WJ. Calcium entry and mobilization signaling pathways in ANG II-induced renal vasoconstriction in vivo. Am J Physiol Renal Fluid Electrolyte Physiol 270: F398-F405, 1996.
32. Tharaux P-L, Dussaule J-C, Pauti M-D, Vassitch Y, Ardaillou R, and Chatziantoniou C. Activation of renin synthesis is dependent on intact nitric oxide production. Kidney Int 51: 1780-1787, 1997.
33. Thorup C and Persson AEG. Inhibition of locally produced nitric oxide resets tubuloglomerular feedback mechanism. Am J Physiol Renal Fluid Electrolyte Physiol 267: F606-F611, 1994.
34. Tolins JP, Shultz PJ, Raij L, Brown DM, and Mauer SM. Abnormal renal hemodynamic response to reduced renal perfusion pressure in diabetic rats: role of NO. Am J Physiol Renal Fluid Electrolyte Physiol 265: F886-F895, 1993.
35. Turkstra E, Braam B, and Koomans HA. Nitro-L-arginine (NLA) increases efficacy of renal blood flow (RBF) autoregulation (AR) in normal and two-kidney, one-clip hypertensive (2K1C) rats (Abstract). J Ant Soc Nephrol 8: 309A, 1997.
36. G-hydroxy-L-arginine prevents the haemodynamic effects of nitric oxide synthesis inhibition in the anaesthetized rat. Br J Pharmacol 107: 476-480, 1992.
37. Wallenstein S, Zucker CL, and Fleiss JL. Some statistical methods useful in circulation research. Circ Res 47: 1-9, 1980.